Japan Home versus Office Measurement Evaluation for Heart Rate study

Japan Home versus Office Measurement Evaluation for Heart Rate study - J-HOME-HR study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001276

Enrollment

Registered

2008-08-01

Start date

2008-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Interventions

Administration of beta blockers

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Essential hypertensive patient receiving antihypertensive drug, 2.Patient who have been measured home blood pressure using upper-arm cuff device, 3.Patient with averaged morning home systolic BP >=135 mmHg and/or diastolic BP >=85 mmHg and averaged morning home heart rate >= 65bpm, 4.Patient who can measure electrocardiogram at home or in the office, 5.Patient aged 20-79 years

Exclusion criteria

Exclusion criteria: 1.Taking beta blockers, anti arrhythmic drug, cardio tonic, or bradycardiac drug within a month, 2.Contraindications or hypersensitivity to beta blockers use, 3.Pulmonary disease, severe diabetes mellitus, or hyperthyroidism, 4.Malignant hypertension, 5.Secondary hypertension, 6.Not available for informed consent, 7.Participating other intervention trials, 8.Severe complications leading to stop this study, 9.Other inappropriate conditions judged by each physician

Design outcomes

Primary

Measure	Time frame
Home heart rate	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026